Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome

NCT03042637 is registered in ClinicalTrials.gov with Southeast Renal Research Institute as lead sponsor.

NCT NCT03042637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome
Lead sponsor
Southeast Renal Research Institute
Phase
Observational
Overall status
Suspended
Start date
January 31, 2012
Completion date
December 31, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome